Guizhou Xinbang Pharmaceutical Ltd. is about to acquire Kekai Medicine Ltd. with RMB 997 million.  

Kekai Medicine’s core businesses are drug distribution and health care service in Guizhou Province. Kekai operates in pharmaceutical R&D and manufacturing, wholesaling and retailing of medical devices and health care service. Through the acquisition, Xinbang Phama could own the whole chain of medical service covering from Pharmaceutical R&D and manufacturing, medicine logistical service and health care service, to which could maximise company’s core competency and market performance.